- Home
- BRN vs OSRH Comparison
BRN vs OSRH Comparison
Compare BRN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- OSRH
- Stock Information
- Founded
- BRN 1956
- OSRH N/A
- Country
- BRN United States
- OSRH United States
- Employees
- BRN N/A
- OSRH N/A
- Industry
- BRN Oil & Gas Production
- OSRH
- Sector
- BRN Energy
- OSRH
- Exchange
- BRN Nasdaq
- OSRH Nasdaq
- Market Cap
- BRN 11.4M
- OSRH 11.1M
- IPO Year
- BRN N/A
- OSRH N/A
- Fundamental
- Price
- BRN $1.16
- OSRH $0.58
- Analyst Decision
- BRN
- OSRH
- Analyst Count
- BRN 0
- OSRH 0
- Target Price
- BRN N/A
- OSRH N/A
- AVG Volume (30 Days)
- BRN 23.8K
- OSRH 13.8M
- Earning Date
- BRN 08-13-2025
- OSRH 08-14-2025
- Dividend Yield
- BRN N/A
- OSRH N/A
- EPS Growth
- BRN N/A
- OSRH N/A
- EPS
- BRN N/A
- OSRH N/A
- Revenue
- BRN $18,073,000.00
- OSRH $104,735.00
- Revenue This Year
- BRN N/A
- OSRH N/A
- Revenue Next Year
- BRN N/A
- OSRH N/A
- P/E Ratio
- BRN N/A
- OSRH N/A
- Revenue Growth
- BRN N/A
- OSRH N/A
- 52 Week Low
- BRN $1.08
- OSRH $0.45
- 52 Week High
- BRN $2.42
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- BRN 51.05
- OSRH 41.12
- Support Level
- BRN $1.13
- OSRH $0.74
- Resistance Level
- BRN $1.29
- OSRH $1.24
- Average True Range (ATR)
- BRN 0.05
- OSRH 0.11
- MACD
- BRN 0.00
- OSRH 0.01
- Stochastic Oscillator
- BRN 23.53
- OSRH 15.50
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.